im-3分子表达异常与原因不明复发性流产的关系
bnormal Expression of Tim-3 in Unexplained Recurrent Spontaneous Abortion
目的:探究T细胞免疫球蛋白粘蛋白分子3(Tim-3)表达异常与不明原因复发性流产(URSA)的关系。方法:选择31例URSA患者作为研究组,并以同期30例正常孕妇作为对照组。采用流式细胞术检测两组外周血单个核细胞(PBMC)中CD4+Tim-3+细胞/CD4+细胞的比例,免疫磁珠法分选CD4+Tim-3+细胞,以荧光定量RT-PCR检测两组外周血PBMC、CD4+Tim-3+细胞及蜕膜组织中Tim-3 mRNA的表达,并以Western Blot技术检测PMBC及蜕膜中Tim-3蛋白的相对含量。结果:URSA组中,PBMC中CD4+Tim-3+细胞/CD4+细胞为5.23±0.96%,蜕膜中Tim-3蛋白的相对表达量为0.64±0.09,PBMC及蜕膜中Tim-3 mRNA的相对表达量为0.65±0.09及0.50±0.07,均显著高于正常对照组(P<0.01)。但是,URSA组Th1细胞Tim-3 mRNA的表达量低于正常对照组,差异具有显著性(P<0.01)。结论:Th1细胞Tim-3表达降低,Th1细胞过度活化可能参与了URSA的发生发展过程。
Objective: To explore the relationship between abnormal expression of T cell immunoglobulin- and mucin-domain containing molecular-3 (Tim-3) and unexplained recurrent spontaneous abortion (URSA). Method: 31 pregnant women suffered with URSA were recruited as the study group and 30 normal pregnant women were chosen as the control group. For the two groups, CD4+Tim-3+cells/CD4+cell percentage in peripheral blood mononuclear (PBMC) were detected by flow cytometry. Then CD4+Tim-3+cells were collected by magnetic activated cell sorting. The expression levels of Tim-3 mRNA in PBMC, CD4+Tim-3+cells and decidua were detected by fluorescent quantitative RT-PCR. Besides, the relative amount of Tim-3 protein were also analyzed using Western blot. Result: In URSA group, the CD4+Tim-3+cells/CD4+cell percentage in PBMC was 5.23±0.96%, the relative level of Tim-3 protein in decidua was 0.64±0.09, the relative amounts of Tim-3 mRNA in PBMC and decidua were 0.65±0.09 and 0.50±0.07 respectively, which were all significantly higher that those in the control group. However, the expression of Tim-3 mRNA on Th1 cells in the URSA group was statistically lower than that in normal control. Conclusion: Down-regulation of Tim-3 on Th1 cells and excessive activation of Th1 might contribute to the development of URSA.
张元珍、周春、刘文惠、张铭、肖嘉伟
妇产科学基础医学分子生物学
复发性流产母胎免疫耐受im-3h1细胞
recurrent abortionmaternal-fetal immune toleranceTim-3Th1 cell
张元珍,周春,刘文惠,张铭,肖嘉伟.im-3分子表达异常与原因不明复发性流产的关系[EB/OL].(2011-10-31)[2025-07-25].http://www.paper.edu.cn/releasepaper/content/201110-342.点此复制
评论